Continuous directed evolution using engineered human B cell lines
This study describes the development of a continuous directed evolution platform in human B cell lines (CODE-HB) that repurposes the somatic hypermutation (SHM) mechanisms to evolve cytoplasmic reporter proteins as well as therapeutically relevant antibodies.